{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:20Z","timestamp":1791919520429,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1124\/dmd.105.004242","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T00:43:44Z","timestamp":1123202624000},"page":"1657-1660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["IMPORTANCE OF CYP2D3 IN POLYMORPHISM OF DIAZEPAM P-HYDROXYLATION IN RATS"],"prefix":"10.1016","volume":"33","author":[{"given":"Noriaki","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konomu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Sub","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Kazusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Funae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.105.004242_bib1","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/0006-2952(86)90493-4","article-title":"Bufuralol 1\u2032-hydroxylase activity of the rat. Strain differences and the effects of inhibitors.","volume":"35","author":"Boobis","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.004242_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0090-9556(24)15275-0","article-title":"Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.","volume":"27","author":"Chow","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004242_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(25)10257-7","article-title":"Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.","volume":"264","author":"Fujita","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.105.004242_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/dna.1987.6.149","article-title":"Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping and molecular analysis of the DA rat polymorphism.","volume":"6","author":"Gonzalez","year":"1987","journal-title":"DNA"},{"key":"10.1124\/dmd.105.004242_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1124\/dmd.30.9.970","article-title":"Catalytic specificity of CYP2D isoforms in rats and human.","volume":"30","author":"Hiroi","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004242_bib6","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/0006-2952(89)90433-4","article-title":"The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.","volume":"38","author":"Kobayashi","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.004242_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of the bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (Lond)"},{"key":"10.1124\/dmd.105.004242_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/347103a0","article-title":"Image analysis for all.","volume":"347","author":"Lennard","year":"1990","journal-title":"Nature (Lond)"},{"key":"10.1124\/dmd.105.004242_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.105.004242_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/dna.1990.9.443","article-title":"Specific cytosine demethylations within the first exons of the rat CYP2D3 and CYP2D5 genes are associated with activation of hepatic gene expression during development.","volume":"9","author":"Matsunaga","year":"1990","journal-title":"DNA Cell Biol"},{"key":"10.1124\/dmd.105.004242_bib11","doi-asserted-by":"crossref","DOI":"10.3109\/00498259509061910","article-title":"Anti-peptide antibodies to the P4502D subfamily in rat, dog and man.","volume":"25","author":"Nakamura","year":"1995","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.105.004242_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-2952(93)90377-9","article-title":"Characterization of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats.","volume":"45","author":"Neville","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.105.004242_bib13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes.","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.105.004242_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jps.20050","article-title":"Polymorphism in diazepam metabolism in Wistar rats.","volume":"93","author":"Saito","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.105.004242_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0090-9556(24)02979-9","article-title":"Strain differences in diazepam metabolism at its three metabolic sites in Sprague-Dawley, Brown Norway, Dark Agouti and Wistar strain rats.","volume":"32","author":"Saito","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004242_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008571-199906000-00011","article-title":"Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.","volume":"9","author":"Schulz-Utermoehl","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.105.004242_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0090-9556(25)08577-0","article-title":"Purification and characterization of cytochrome P-450 isozyme catalyzing bunitorolol 4-hydroxylation in liver microsomes of male rats.","volume":"20","author":"Suzuki","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004242_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2220\/biomedres.17.331","article-title":"Impaired expression in DA rats of catalytically active P450BTL, immunochemically distinguishable from P4502D1: immunological evidence with specific anti-peptide antibodies.","volume":"17","author":"Yamamoto","year":"1996","journal-title":"Biomed Res"},{"key":"10.1124\/dmd.105.004242_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199802000-00010","article-title":"Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.","volume":"8","author":"Yamamoto","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.105.004242_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/abbi.1997.0402","article-title":"Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.","volume":"348","author":"Wan","year":"1997","journal-title":"Arch Biochem Biophys"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624033142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624033142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.105.004242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:55:42Z","timestamp":1739901342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624033142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0090955624033142"],"URL":"https:\/\/doi.org\/10.1124\/dmd.105.004242","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMPORTANCE OF CYP2D3 IN POLYMORPHISM OF DIAZEPAM P-HYDROXYLATION IN RATS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.105.004242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}